Glenn Killingworth has joined PCI Synthesis, a custom chemical manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients (APIs), complex pharmaceutical intermediates and other specialist products, as Vice President of Business Development.
In his new role, Killingworth will drive business growth through the development and implementation of PCI's sales and marketing strategy and building and leading business development teams to embrace new opportunities for PCI in current and new markets worldwide.
An organic chemistry specialist, Killingworth brings 25 years of experience working for specialist companies including Fisher Scientific, Peakdale Molecular, Almac Sciences, WuXi Apptec and Asymchem. He has spent the last decade in commercial and business development roles.
Killingworth will be based at the company's Newburyport, MA headquarters.